Bioinformatic Analysis of Related Genes and Therapeutic Drugs of Asthma
10.13422/j.cnki.syfjx.20191458
- VernacularTitle:哮喘相关基因与治疗药物的生物信息学分析
- Author:
Xiu-fang HUANG
1
;
Gang LIAO
2
;
Yun-ji GAO
2
;
Shao-feng ZHAN
3
;
Hui-ting HUANG
3
;
Yan-ni LAI
1
;
Xiao-hong LIU
3
Author Information
1. The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou 510405, China
2. Shenzhen Hospital of Guangzhou University of Chinese Medicine, Shenzhen 518000, China
3. Guangdong Provincial Inheritance Studio of Famous Traditional Chinese Medicine of LIU Xiao-hong, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China
- Publication Type:Research Article
- Keywords:
asthma;
differentially expressed genes;
hub genes;
gene ontology;
Kyoto encyclopedia of genes and genomes;
protein-protein interaction;
small molecule drugs
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2020;26(2):155-163
- CountryChina
- Language:Chinese
-
Abstract:
Objective::Bioinformatic analysis was used to compare the gene expression profile between asthma patients and healthy people, and the gene characteristics of asthma were preliminarily identified and the potential mechanism and drugs were revealed. Method::The GSE74986 gene expression profile was downloaded from the gene expression omnibus (GEO) and the differentially expressed genes (DEGs) were analyzed by GEO2R. Then the gene heat map of DEGs was made by Morpheus, and their gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) analysis were performed by DAVID 6.8. Moreover, the protein-protein interaction (PPI) network and hub genes were constructed by String 10.5. Finally, the significant modules were analyzed by MCODE in Cytoscape 3.6.1, small molecule drugs related to asthma were screened through Coremine Medical. Result::A total of 510 DEGs were screened, including 29 up-regulated genes and 481 down-regulated genes. DEGs were mainly involved in these biological processes and pathways, including chromatin silencing, transcriptional regulation of RNA polymerase Ⅱ promoter, protein transport, messenger RNA (mRNA) processing, RNA splicing, ubiquitin-mediated proteolysis, protein processing in the endoplasmic reticulum, RNA transport, and myeloid differentiation factor (MyD)-dependent Toll-like receptor signaling pathway, platelet activation, nucleotide binding oligomerization domain (NOD)-like receptor signaling pathway and so on. A total of 9 hub genes were obtained, including T-complex protein 1 subunit theta (CCT8), T-complex protein 1 subunit alpha (TCP1), 26S protease regulatory subunit S10B (PSMC6), heat shock protein 90 alpha (HSP90A)A1, cell cycle protein C (CCNC), HSP90AB1, 26S proteasome non-ATPase regulatory subunit 6 (PSMD6), ubiquitin-specific protease 14 (USP14) and eukaryotic translation initiation factor 4E (EIF4E). Two important modules were obtained. The genes in two modules mainly involved these biological process, such as splice, ubiquitin-mediated proteolysis, protein modification, RNA modification and so on. Some potential molecular drugs for the treatment of asthma, such as anisomycin and genistein, have been developed. Conclusion::DEGs and hub genes can contribute to understanding the molecular mechanism of asthma and providing potential therapeutic targets and drugs for the diagnosis and treatment of asthma.
